Literature DB >> 14522326

Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma.

Scott T Hollenbeck1, Stephen R Grobmyer, K Craig Kent, Murray F Brennan.   

Abstract

BACKGROUND: The inferior vena cava (IVC) is a rare site for primary soft tissue sarcoma. There are limited data in the literature regarding surgical management of the IVC and longterm survival of these patients. STUDY
DESIGN: From 1982 to 2002, a total of 25 patients with primary IVC leiomyosarcoma was treated as inpatients and followed in a prospective database at Memorial Sloan-Kettering. Presenting symptoms, tumor characteristics, operative management, postoperative morbidity, and disease-specific survival were assessed for each patient.
RESULTS: The 25 patients with primary IVC leiomyosarcoma accounted for 0.5% of all adult patients with soft tissue sarcoma treated during this time. The median patient age was 56 years (range 41 to 79 years). The three most common presenting symptoms were abdominal pain (52%), distention (20%), and deep venous thrombosis (12%). Of the patients, 21 (84%) underwent complete resection of the tumor. The IVC was managed in one of three ways: ligation (n = 11), primary/patch repair (n = 8), and expanded polytetrafluoroethylene tube grafting (n = 2). Among patients undergoing IVC ligation and primary/patch repair (n = 19), 11% had severe postoperative edema and none had worsening renal function. Local recurrence occurred in 33% of patients and distant recurrence occurred in 48% of patients. Patients undergoing complete resection had 3-year and 5-year disease-specific survival rates of 76% and 33%, respectively. There were no 3-year survivors among patients with incomplete resections.
CONCLUSIONS: Complete resection of primary IVC leiomyosarcomas is feasible and associated with improved survival. The IVC can be managed by primary repair or ligation with a low risk of severe postoperative edema.

Entities:  

Mesh:

Year:  2003        PMID: 14522326     DOI: 10.1016/S1072-7515(03)00433-2

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  60 in total

Review 1.  [Vascular replacement in abdominal tumor surgery].

Authors:  A Mehrabi; P Houben; N Attigah; D Böckler; M W Büchler; J Weitz
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

2.  Leiomyosarcoma of the renal vein.

Authors:  Tetsuya Imao; Toshiyasu Amano; Katsurou Takemae
Journal:  Int J Clin Oncol       Date:  2010-08-07       Impact factor: 3.402

3.  Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.

Authors:  Christina L Roland; Genevieve M Boland; Elizabeth G Demicco; Kristelle Lusby; Davis Ingram; Caitlin D May; Christine M Kivlin; Kelsey Watson; Ghadah A Al Sannaa; Wei-Lien Wang; Vinod Ravi; Raphael E Pollock; Dina Lev; Janice N Cormier; Kelly K Hunt; Barry W Feig; Alexander J Lazar; Keila E Torres
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

4.  Renal vein leiomyosarcoma and renal cell carcinoma presenting together: A case report and discussion on the follow-up.

Authors:  Conor M Devlin; Kanwar Gill; Jennifer Thomas; Chandra Shekhar Biyani
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

5.  Resection and reconstruction of the inferior vena cava for neoplasms.

Authors:  Nikola Nikolov Vladov; Vassil Ivanov Mihaylov; Nikolai Vassilev Belev; Ventzislav Metodiev Mutafchiiski; Ivelin Rumenov Takorov; Sergei Kirilov Sergeev; Evelina Hristova Odisseeva
Journal:  World J Gastrointest Surg       Date:  2012-04-27

6.  Leiomyosarcoma of the inferior vena cava: a case report and review of the literature.

Authors:  Venkataprasanth P Reddy; Peter J Vanveldhuizen; Gregory F Muehlebach; Reginald W Dusing; James P Birkbeck; Stephen K Williamson; Leela Krishnan; David G Meyers
Journal:  Cases J       Date:  2010-02-23

7.  [Therapeutic management of intra-abdominal and retroperitoneal soft tissue sarcomas].

Authors:  S Wong; M F Brennan
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

8.  [Leiomyosarcoma of the inferior vena cava. Review of a rare disease].

Authors:  A M Müller; A M Chromik; B Bolik; K-M Müller; U Mittelkötter
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

9.  Leiomyosarcoma of the inferior vena cava.

Authors:  Sarah Jenkins; Geoffrey B Marshall; Robin Gray
Journal:  Can J Surg       Date:  2005-06       Impact factor: 2.089

Review 10.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.